Phathom Pharmaceuticals, Inc. (PHAT) earnings
PHAT earnings moved a median of -1.29% by the close. Quarterly and annual PHAT reports and results, each read against the price at its own news timestamp. Back to the PHAT overview →
32 measured PHAT earnings events.
Where these PHAT earnings landedvs 32 measured PHAT earnings reactions
| Middle 50% of PHAT earnings reactions | -4.93% to +2.24% |
|---|---|
| Median reaction (to close) | -1.29% |
| Measured reactions | 32 |
Point-in-time · zero look-ahead
Half of the 32 PHAT earnings events with a measured close landed between -4.93% and +2.24%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026 | Press release | +1.60% | +1.89% | |
| Form 10-Q Phathom Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +13.08% | +1.46% | |
| Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +13.08% | +1.46% | |
| Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026 | Press release | +2.05% | -2.29% | |
| Form 10-Q Phathom Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -2.09% | -2.27% | |
| Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -2.09% | -2.27% | |
| Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026 | Press release | -0.39% | +2.43% | |
| Form 10-K Phathom Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +1.51% | +4.71% | |
| Form 10-Q Phathom Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +4.79% | -4.93% | |
| Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +4.79% | -4.93% | |
| Phathom Pharmaceuticals to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, October 30, 2025 | Press release | +2.22% | +7.44% | |
| Form 10-Q Phathom Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +7.06% | +2.06% | |
| Phathom Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates | Press release | +7.06% | +2.06% | |
| Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025 | Press release | +2.49% | -8.62% | |
| Form 10-Q Phathom Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -7.25% | -16.00% | |
| Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | -7.25% | -16.00% | |
| Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025 | Press release | +4.62% | -2.19% | |
| Form 10-K Phathom Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +15.41% | +3.33% | |
| Form 10-Q Phathom Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -1.03% | -11.03% | |
| Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates | Press release | -10.76% | -1.49% | |
| Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024 | Press release | +2.37% | +6.89% | |
| Form 10-Q Phathom Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.51% | -1.09% | |
| Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | +1.30% | +2.17% | |
| Phathom Pharmaceuticals to Report Second Quarter 2024 Financial Results and Provide Business Update on Thursday, August 8, 2024 | Press release | -2.29% | -2.96% | |
| Form 10-K/A Phathom Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -1.06% | +3.36% | |
| Form 10-Q/A Phathom Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.06% | +3.36% | |
| Form 10-Q Phathom Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.29% | -6.25% | |
| Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | +7.32% | +4.02% | |
| Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024 | Press release | +0.33% | +1.30% | |
| Form 10-K Phathom Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.71% | -3.16% | |
| Form 10-Q Phathom Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -0.18% | -6.21% | |
| Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates | Press release | -0.18% | -6.21% |
Keep exploring
More PHAT: analyst actions → · SEC filings → · PHAT overview →